CTOR
Citius Oncology
CTOR
CTOR
23 hedge funds and large institutions have $69M invested in Citius Oncology in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.01M | |
| 2 | +$2.46M | |
| 3 | +$2.08M | |
| 4 |
CAC
Cowen and Company
New York
|
+$468K |
| 5 |
MSU
Mizuho Securities USA
New York
|
+$349K |
Top Sellers
| 1 | -$2.42M | |
| 2 | -$656K | |
| 3 | -$394K | |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$157K |
| 5 |
VF
Virtu Financial
New York
|
-$130K |